Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

128.96USD
24 May 2019
Change (% chg)

$4.31 (+3.46%)
Prev Close
$124.65
Open
$125.09
Day's High
$129.64
Day's Low
$125.09
Volume
68,746
Avg. Vol
94,459
52-wk High
$131.69
52-wk Low
$53.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 10.52 -0.760
Sep '18 0.02 -0.811
Jun '18 0.02 -0.547
Mar '18 0.03 -1.069
FY 2017 Dec '17 0.28 -0.925
Sep '17 0.43 -1.039
Jun '17 0.44 -0.945
Mar '17 0.37 -0.775
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 5 0.05 0.22 0.00 0.30
Quarter Ending Sep-19 5 0.05 0.24 0.00 0.30
Year Ending Dec-19 8 1.40 10.00 0.00 3.03
Year Ending Dec-20 9 13.25 88.21 0.00 10.06
Earnings (per share)
Quarter Ending Jun-19 6 -1.02 -0.92 -1.18 -0.94
Quarter Ending Sep-19 6 -1.05 -0.81 -1.27 -1.03
Year Ending Dec-19 9 -4.09 -2.87 -4.97 -3.32
Year Ending Dec-20 9 -4.09 -0.07 -6.06 -4.33
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 93.20 35.48
P/E High - Last 5 Yrs. -- 165.14 57.43
P/E Low - Last 5 Yrs. -- 51.92 28.10
Beta 0.82 1.21 0.95
Price to Sales (TTM) 503.77 40.13 9.28
Price to Book (MRQ) 17.32 11.48 4.15
Price to Tangible Book (MRQ) 19.27 16.72 4.94
Price to Cash Flow (TTM) -- 61.14 24.38
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.68
Dividend Yield - 5 Year Avg -- 0.06 1.30
Dividend 5 Year Growth Rate -- 0.94 6.71
Payout Ratio(TTM) -- 1.56 35.42

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 3,655.36 59.08 16.40
Sales (TTM) vs TTM 1 Yr. Ago 591.57 46.19 8.26
Sales - 5 Yr. Growth Rate -12.31 32.98 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 17.78 -9.33 19.71
EPS (TTM) vs TTM 1 Yr. Ago 13.48 -- --
EPS - 5 Yr. Growth Rate -- 22.17 7.23
Capital Spending - 5 Yr. Growth Rate 17.25 24.87 8.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.77 2.43
Current Ratio (MRQ) 7.53 3.84 3.36
LT Debt to Equity (MRQ) 0.00 7.71 14.37
Total Debt to Equity (MRQ) 0.00 20.81 19.78
Interest Coverage (TTM) -8.69 32.37 13.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 22.42 50.23
Gross Margin - 5 Yr. Avg. -- 59.23 51.31
EBITD Margin (TTM) -1,454.28 -- --
EBITD - 5 Yr. Avg -1,003.86 -16.11 15.84
Operating Margin (TTM) -1,462.59 -116.39 -4.60
Operating Margin - 5 Yr. Avg. -1,012.50 -31.95 11.09
Pre-Tax Margin (TTM) -1,233.26 -116.40 -4.95
Pre-Tax Margin - 5 Yr. Avg. -946.75 -34.49 15.89
Net Profit Margin (TTM) -1,229.53 -121.99 -8.72
Net Profit Margin - 5 Yr. Avg. -940.49 -39.40 11.14
Effective Tax Rate (TTM) -- 17.16 19.94
Effective Tax Rate - 5 Yr. Avg. -- 18.91 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 54,874 8,861,170 746,541,307
Net Income/Employee (TTM) -674,696 1,554,572 87,192,468
Receivable Turnover (TTM) 109.08 11.38 5.67
Inventory Turnover (TTM) -- 2.45 3.66
Asset Turnover (TTM) 0.04 0.33 0.79

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -49.10 6.13 9.44
Return on Assets - 5 Yr. Avg. -47.76 6.07 10.47
Return on Investment (TTM) -55.68 7.47 11.75
Return on Investment - 5 Yr. Avg. -54.24 7.95 13.33
Return on Equity (TTM) -55.68 7.94 16.52
Return on Equity - 5 Yr. Avg. -54.24 9.00 14.90
  1 Year 3 Year 5 Year
Sales % 591.57 9.23 -12.31
EPS (TTM) % 14.06 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ascendis Pharma A/S

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 17.17 21.89 99 7
13 Week 79.14 77.02 99 16
26 Week 118.95 103.96 99 7
52 Week 93.92 87.18 99 12
YTD 105.84 82.59 99 4
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 99.96%
# of Holders: 162
Total Shares Held: 46,282,447
3 Mo. Net Change: 6,026,454
# New Positions: 53
# Closed Positions: 14
# Increased Positions: 102
# Reduced Positions: 59
# Net Buyers: 43
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.